ICOPE Program Feasibility in the Management of Myeloma Patients

Sponsor
University Hospital, Toulouse
Study ID
NCT06247189
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
70 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ICOPE Monitoring — OTHER
    At inclusion set up of the ICOPE monitor program on the patient's device and evaluation (all steps) of ICOPE Monitor program. Monthly, re-evaluation of the patient (Step 1 and others if necessary ) according to the ICOPE Monitor program

Study Details

This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.

Key Dates

First listed
Feb 7, 2024
Start date
Dec 3, 2025
Status verified
Dec 2025
Primary completion
Dec 3, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: ICOPE Monitor Program
    Evaluation at inclusion and re-evaluation monthly.

Primary Outcome Measure

Feasibility of the implementation [ Time Frame: 12 months ]

Central Contacts

Find similar trials

Nationwide
Multiple myeloma trialsOncology trialsBlood cancer trials

Related Studies